Santiago Salguero, executive director of the Association of Latin American Pharmaceutical Laboratories in Ecuador (ALAFAR), elaborates on the exceptional work done by the association to build the relevant quality of products manufactured by his member companies, additional services the association can provide to its associates as well as the unmatched locational and economic advantages Ecuador has to offer for pharmaceutical laboratories. Finally, he highlights the regulatory obstacles ALAFAR will be looking forward to clear in collaboration with the recently elected national government.
Mr. Salguero, you have been the executive director of ALAFAR since June 2009. Could you briefly introduce yourself to our international readers and the key achievements of the association in recent years?
"Ecuador is a target country for pharmaceutical companies, notably because the country’s dollarized economy is a protection the economic variations one can witness in other Latin American markets."
